DSM-Firmenich

A merger of equals

The leading creation and innovation partner

DSM and Firmenich have announced an intention to merge, signing a definitive agreement to establish the leading nutrition, beauty and well-being partner.

More information, including recordings of webcasts to investors and media, plus all the documents associated with this transaction are available at www.creator-innovator.com.

Offering Circular & EGM announcement

22 Nov 2022

DSM and Firmenich jointly announced the launch of the exchange offer to DSM shareholders as part of the merger of equals to create DSM-Firmenich. An Extraordinary General Meeting will be held on Monday 23 January 2023.

More information for DSM shareholders can be found here.

The press release and associated information, including the recording of a presentation and Q&A with analysts and investors, can be accessed here.

Investor Roadshow

London - 24-25 November 2022   

  • Broker: Citi

Netherlands - 28 November 2022                      

  • Broker: ING

Paris - 28-29 November 2022                 

  • Broker: Exane

Geneva - 30 November 2022                       

  • Broker: UBS

Frankfurt - 2 December 2022                          

  • Broker: Kepler Cheuvreux

Brussels - 6 December 2022                          

  • Broker: ING

New York - 8-9 December 2022                      

  • Broker: Barclays

Copenhagen – Stockholm - 15-16 December 2022                  

  • Broker: Danske

Update on public exchange offer process

28 Jun 2022

Pursuant to Section 7, paragraph 1 sub a of the Netherlands Decree on Public Takeover Bids (Besluit openbare biedingen Wft), which requires a public announcement containing a status update on an intended public offer within four weeks after its initial public announcement, DSM and Firmenich confirm that they are making good progress on the preparations for the Offer.

The press release can be accessed here

Capital Markets Day

13 Jun 2022

DSM and Firmenich hosted a joint Capital Markets Day for institutional investors and equity analysts, to provide a deeper understanding of Firmenich’s businesses and to present DSM-Firmenich, outlining its key value drivers, demonstrating how the complementary nature of the companies can enable enhanced innovation and co-creation with their customers, and through this, increase returns and deliver long-term sustainable growth and shareholder value.

Held at the Palais Brongniart, the historical Paris stock exchange, the recording of the presentations and the Q&A session is available to be watched back here.

Future leadership team confirmed

13 Jun 2022

DSM and Firmenich jointly announced the future leadership team for DSM-Firmenich. The Executive Committee will have a balanced team of talented individuals drawn from both DSM and Firmenich and representing the diversity, skillset, and ambitions of the combined company.

The press release can be accessed here

Merger announcement

31 May 2022

DSM and Firmenich announced an intention to merge to become the leading creation and innovation partner in nutrition, beauty and well-being. The combination will bring together Firmenich’s unique leading Perfumery and Taste businesses, its world-class science platforms and associated co-creation capabilities with DSM’s outstanding Health and Nutrition portfolio and renowned scientific expertise.

The press release can be accessed here

Read more